Literature DB >> 1080955

Endothelial alterations in congenital corneal dystrophies.

M M Rodrigues, G O Waring, P R Laibson, S Weinreb.   

Abstract

We studied the clinical and ultrastructural findings in three different types of congenital endothelial dystrophies: hereditary posterior polymorphous dystrophy, congenital hereditary corneal dystrophy, and a nonhereditary congenital endothelial dystrophy. In the first patient, with hereditary posterior polymorphous dystrophy, a layer of epithelial-like cells was observed adjacent to endothelial cells on the posterior corneal surface. Descemet's membrane displayed a multilaminar pattern and consisted of an anterior, thin (3 mu), PAS-positive layer and a posterior, thicker (25 to 30 mu) zone of abnormal collagen. The second patient, with congenital hereditary endothelial dystrophy, showed a thickened multilaminar Descemet's membrane and scant endothelial cells. In the third patient with nonhereditary congenital endothelial dystrophy, the thickened Descemet's membrane was lined posteriorly by a retrocorneal fibrous membrane. A few degenerated endothelial cells were present. All three cases showed 100- to 110-nm banding posteriorly. In these three clinically distinct entities, electron microscopy was useful in demonstrating the unusual form of endothelial transformation to epithelial-like cells in one patient, in contrast to the more common fibroblast-like metaplasia of endothelial cells seen in the other two patients.

Entities:  

Mesh:

Year:  1975        PMID: 1080955     DOI: 10.1016/0002-9394(75)90400-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  14 in total

Review 1.  Molecular bases of corneal endothelial dystrophies.

Authors:  Thore Schmedt; Mariana Mazzini Silva; Alireza Ziaei; Ula Jurkunas
Journal:  Exp Eye Res       Date:  2011-08-10       Impact factor: 3.467

2.  Posterior polymorphous dystrophy: a light and electron microscopic study.

Authors:  B L Johnson; S I Brown
Journal:  Br J Ophthalmol       Date:  1978-02       Impact factor: 4.638

3.  Homozygosity mapping and linkage analysis demonstrate that autosomal recessive congenital hereditary endothelial dystrophy (CHED) and autosomal dominant CHED are genetically distinct.

Authors:  M Callaghan; C K Hand; S M Kennedy; J S FitzSimon; L M Collum; N A Parfrey
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

4.  A clinicopathologic study of posterior polymorphous dystrophy:implications for pathogenetic mechanism of the associated glaucoma.

Authors:  A B Threlkeld; W R Green; H A Quigley; Z de la Cruz; W J Stark
Journal:  Trans Am Ophthalmol Soc       Date:  1994

5.  Posterior polymorphous dystrophy of the cornea (Schlichting). An unusual clinical variant.

Authors:  H Witschel; R Sundmacher; H Theopold; W Jaeger
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1980

6.  Posterior polymorphous corneal dystrophy: a disease characterized by epithelial-like endothelial cells which influence management and prognosis.

Authors:  J H Krachmer
Journal:  Trans Am Ophthalmol Soc       Date:  1985

7.  Immuno-electron labelling of matrix components in congenital hereditary endothelial dystrophy.

Authors:  W Sekundo; G E Marshall; W R Lee; C M Kirkness
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-06       Impact factor: 3.117

8.  Congenital hereditary corneal oedema of Maumenee: its clinical features, management, and pathology.

Authors:  C M Kirkness; A McCartney; N S Rice; A Garner; A D Steele
Journal:  Br J Ophthalmol       Date:  1987-02       Impact factor: 4.638

9.  Posterior polymorphous dystrophy of the cornea. An ultrastructural study.

Authors:  G P de Felice; P Braidotti; G Viale; F Bergamini; P Vinciguerra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

10.  Induction of FGF-2 synthesis by IL-1beta in aqueous humor through P13-kinase and p38 in rabbit corneal endothelium.

Authors:  Jong-Suk Song; Jeong Goo Lee; EunDuck P Kay
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-09-24       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.